Oncology News | pharmaphorum

News

NHS will roll out ‘lifeline’ endometrial cancer regimen

The NHS has agreed a pair of commercial deals with Merck & Co/MSD and Eisai that will allow hundreds of women with advanced endometrial cancer to get access to life-ex

News

Servier doubles up on ‘digital twin’ alliance with Aitia

French pharma group Servier has formed a second partnership with Aitia focusing on the use of artificial intelligence and

News

AZ posts first-line combo data for lung cancer drug Tagrisso

AstraZeneca’s top-selling drug Tagrisso is already widely used on its own as a first-line treatment for EGFR-mutated lung cancer, but new data suggests there can be benefi

News

Boundless Bio raises $100m for circular DNA cancer therapy

Boundless Bio’s plans to develop a new class of cancer therapies targeting DNA found outside the nucleus of malignant cells have been boosted by a $100 million fundraising

News

And Astellas’ latest drug discovery partner is… Sony?

Astellas Pharma has looked outside of the box for its latest cancer drug development partnership, joining forces with Sony on a project to find new antibody-drug conjugate

News

AstraZeneca builds in cancer ADCs again, with LaNova deal

AstraZeneca has looked to China for another antibody-drug conjugate (ADC) candidate for cancer, paying $55 million for rights to a preclinical candidate from Shanghai-base

NHS will roll out ‘lifeline’ endometrial cancer regimen

Servier doubles up on ‘digital twin’ alliance with Aitia

AZ posts first-line combo data for lung cancer drug Tagrisso

Boundless Bio raises $100m for circular DNA cancer therapy

And Astellas’ latest drug discovery partner is… Sony?

AstraZeneca builds in cancer ADCs again, with LaNova deal

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks